No Data
Mitsubishi Gas Chemical's Nine Month Profit Falls Over 11%
In the fiscal year ending December 2024, VIS will promote mRNA-targeted small molecule drug discovery business and the creation of its own pipeline.
Veritas In Silico <130A> announced its fiscal results for the year ending December 2024 on the 13th. Business revenue decreased by 46.0% compared to the previous year to 0.194 billion yen, with an operating loss of 0.212 billion yen (compared to a profit of 0.037 billion yen in the previous term), an ordinary loss of 0.233 billion yen (compared to a profit of 0.035 billion yen in the previous term), and a net loss of 0.236 billion yen (compared to a profit of 0.033 billion yen in the previous term). In the company's mRNA-targeted small molecule drug discovery business, the drug discovery platform ibVIS(R) is being utilized, and TORAY INDS INC <3402>.
Stocks that moved or were traded in the first half of the session.
*Takasago International Corporation <4914> 6150 -Significantly revised upward the financial estimates and dividend forecasts. *GMO Internet <4784> 1350 +214 The guidance for this period and expectations for increased dividends continue to have an impact. *PeptiDream <4587> 2343.5 +354 The guidance for increased profits this period is viewed positively. *PKSHA Technology <3993> 4720 +700 The first quarter showed significant profit growth and good progress. *Lion Corporation <4912> 1858.
Haseko, Daiwa House, ETC (additional) Rating
Upgraded - Bullish Code Stock Name Brokerage Firm Previous Change After -------------------------------------------------------- <8056> BIPROGY City "3" "2" Downgraded - Bearish Code Stock Name Brokerage Firm Previous Change After -------------------------------------------------------- <3659> Nexon Nomura "Buy" "
February 14 [Today's Investment Strategy]
[Fisco Selected Issues] [Material Stock] PKSHA Technology <3993> 4020 yen (2/13) Developing AI Algorithms and implementing them as a product in society. The first quarter financial results were announced. Operating profit was 1.039 billion yen (an increase of 32.5% compared to the same period last year). Acquisition of solution projects in the AI Research & Solution business and expansion of product sales in the AI SaaS business. Revenue from the new group company also contributed.
Focus on Sony Group Corp and PKSHA, while Takarachō HD and Mitsubishi perhaps may be sluggish.
In the US stock market yesterday, on the 13th, the Dow Jones Industrial Average rose by 342.87 dollars to 44,711.43, the Nasdaq Composite Index increased by 295.69 points to 19,945.64, and the Chicago Nikkei 225 Futures rose by 40 yen from the Osaka daytime comparison to 39,480 yen. The exchange rate is 1 dollar = 152.80-90 yen. In today's Tokyo market, PKSHA <3993> saw a 32.5% increase in operating profit for the first quarter, with operating profit expected to increase by 38.4% from the previous period and 23.3% this period, alongside the announcement of its medium-term management plan by Lion <491.